COVID-19 vaccine Covishield by Serum Institute: How effective is it? How much will it cost?1 min read . Updated: 05 Jan 2021, 02:24 PM IST
- 'Covishield is highly effective vaccine against novel coronavirus,' said Adar Poonawalla, chief executive officer, Serum Institute of India
- The first 100 million doses of Covishield were being sold to the Indian government at a special price of ₹200, Poonawalla said
India on Sunday approved the emergency authorisation of two vaccines against novel coronavirus — Covaxin by Bharat Biotech and Covishield by Serum Institute of India. Earlier, Britain and Argentina had approved the emergency marker use of coronavirus vaccine developed by the University of Oxford and AstraZeneca. Serum Institute of India, the world's largest vaccine manufacturer by volume, joined hands with British-Swedish drugmaker to produce 1 billion doses of its COVID-19 vaccine. The local version of Oxford-AstraZeneca COVID-19 vaccine will be known as Covishield.
Select your Category